Yuksel Nilay, Akcay Emine, Ayan Berna, Duru Necati
a Department of Ophthalmology , Ankara Ataturk Education and Research Hospital , Ankara , Turkey.
b Department of Ophthalmology , Yildirim Beyazit University, Ankara Ataturk Education and Research Hospital , Ankara , Turkey.
Curr Eye Res. 2017 Mar;42(3):348-350. doi: 10.1080/02713683.2016.1196706. Epub 2016 Jul 15.
To evaluate tear osmolarity (TO) in patients with epiphora caused by primary-acquired nasolacrimal-duct obstruction (PANDO), before and after an external dacryocystorhinostomy (DCR) and to compare with healthy control subjects.
Twenty eyes of 20 patients (15 women, 5 men) who suffered from epiphora for at least one year due to PANDO, and 20 eyes of 20 healthy subjects (13 women, 7 men), were included in this study. External DCR was applied to all patients with PANDO, and TO measurements were repeated during the first month follow-up visit after surgery.
The mean period for complaints of epiphora was 1.7 ± 0.6 years (1-3). Patients had a mean TO of 282.6 ± 10 mOsm/l (range: 269-302) prior to DCR, and this increased to 297.7 ± 7.7 mOsm/l (range: 284-310) one month after DCR (p = 0.0001). Preoperative TO values were significantly lower when compared with the healthy control subjects' (301.7 ± 10.6 mOsm/l (range: 280-316) (p = 0.0001). No significant differences were detected between postoperative and control group TO values (p = 0.18).
Epiphora due to PANDO causes lower TO values. One month after DCR, TO came to similar TO levels when compared to healthy subjects.
评估原发性后天性鼻泪管阻塞(PANDO)所致溢泪患者在接受外路泪囊鼻腔吻合术(DCR)前后的泪液渗透压(TO),并与健康对照者进行比较。
本研究纳入了20例因PANDO溢泪至少1年的患者(15例女性,5例男性)的20只眼,以及20例健康受试者(13例女性,7例男性)的20只眼。所有PANDO患者均接受了外路DCR,并在术后第1个月随访时重复测量TO。
溢泪主诉的平均时长为1.7±0.6年(1 - 3年)。患者在DCR术前的平均TO为282.6±10 mOsm/l(范围:269 - 302),DCR术后1个月增至297.7±7.7 mOsm/l(范围:284 - 310)(p = 0.0001)。与健康对照者(301.7±10.6 mOsm/l,范围:280 - 316)相比,术前TO值显著更低(p = 0.0001)。术后与对照组的TO值之间未检测到显著差异(p = 0.18)。
PANDO所致溢泪导致TO值降低。DCR术后1个月,TO与健康受试者相比达到了相似水平。